This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Suzhou Ribo Life Science Company, Ltd.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: The Innovations of Liangyi Wan
Introduction
Liangyi Wan is a notable inventor based in Kunshan, China. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that enhance the delivery of oligonucleotide drugs. His work focuses on creating solutions that address the challenges associated with drug delivery in vivo.
Latest Patents
Liangyi Wan holds a patent for "Conjugates and preparation and use thereof." This patent describes a compound designed to form a conjugate with an active agent, such as an oligonucleotide, represented by a specific structural formula. The conjugate developed by Wan can specifically target hepatocytes, effectively solving the delivery issues of oligonucleotide drugs while maintaining low toxicity and high stability.
Career Highlights
Wan is currently employed at Suzhou Ribo Life Science Company, Ltd., where he continues to innovate in the field of drug delivery systems. His work has garnered attention for its potential to improve therapeutic outcomes for patients requiring oligonucleotide-based treatments.
Collaborations
Liangyi Wan collaborates with talented individuals in his field, including Hongyan Zhang and Zhiwei Yang. Their combined expertise contributes to the advancement of research and development in biotechnology.
Conclusion
Liangyi Wan's contributions to the field of biotechnology, particularly through his innovative patent, highlight his role as a key inventor in enhancing drug delivery systems. His work promises to make a significant impact on the future of medical treatments.